Psoriasis is an immune-mediated, long-term condition that mostly affects the skin and joints. Thick, scaly, erythematous plaques are often caused by rapid keratinocyte growth.2-3% of percent of people worldwide suffer with psoriasis. The most common treatment for people with mild-to-moderate psoriasis is still topical medicine because of its limited systemic exposure and localized efficacy. Among the most often prescribed topical drugs are corticosteroids, vitamin D analogues, retinoids, coal tar, anthralin, and calcineurin inhibitors. Both traditional and nanotechnology-based approaches for enhancing therapeutic results in psoriasis therapy are compiled in this review. Natural polymers including starch, gelatin, and alginate are used to create biodegradable polymeric microspheres. They safely break down in vivo and are biocompatible. They can be used as controlled-release carriers. Integration of Nanotechnology: Examples of nanosized microspheres for enhanced penetration and site-specific treatment are clobetasol and Apremilast microspheres for psoriasis. Microparticles of sericin and Gelatine are used to lower TNF-α and reduce inflammation. Glycyrrhizic acid and curcumin are coencapsulated to treat pH-sensitive psoriasis. Nanozyme Hydrogel Microspheres: These versatile microspheres can moisturize, scavenge cfDNA, and lower inflammation. Microspheres are produced using a variety of formulation methods, including as spray drying, solvent extraction, microencapsulation, and single- and double-emulsion procedures. These microsphere-based delivery techniques promote extended drug release from the polymeric matrix while improving biocompatibility and physical stability. Furthermore, microspheres show excellent entrapment efficiency and reduce inflammation and the severity of psoriatic lesions, indicating that they may be a helpful platform for targeted therapy of psoriasis.